Coronavirus

More from the Series

Blog Post
Sound Banks for Healthy Economies: A CGD-IDB Report Four Months Later
January 25, 2021
Last fall, CGD and the Inter-American Development Bank (IDB) launched a report by the joint Sound Banks for Healthy Economies working group. We round up highlights from two of those discussions here, organized by common themes that ran through the events. 
Blog Post
COVID-19 is a Gendered Crisis. Here’s What Policymakers Can Do About It.
January 25, 2021
The Center for Global Development is building on our initial efforts by launching the COVID-19 Gender and Development Initiative. This new initiative will aim to promote gender equality and long-term prosperity in low- and middle-income countries by informing global and national decisionmakers' poli...
Blog Post
COVID-19 and the Plague Cycle
January 18, 2021
Charles Kenny launches his latest book The Plague Cycle: The Unending War Between Humanity and Infectious Disease.
Blog Post
A New Year’s Wish: Invest in Data
January 08, 2021
Ranil Dissanayake calls for developing country governments, donors, and researchers to commit to: invest in, and use, national data collection systems.
Blog Post
G7: Make Plans to Share Excess Vaccine Now
January 04, 2021
The reality is that getting back to normal means rapid vaccination of the entire world – to minimize further virus mutations, to enable regular trade and commerce, and to protect those that are unable to be vaccinated for other health reasons.
Blog Post
The Best of 2020: What We Read While the World Burned Around Us (Research Edition)
December 18, 2020
We’ve picked our favourite papers and articles about development of the year, picking pieces that help us understand the problems we’re working on better and how best to fix them.
Blog Post
Questions on the COVID-19 Vaccine? We've Got Answers
December 17, 2020
At a recent CGD staff presentation of our work into COVID-19 vaccines, our colleagues raised a large number of interesting questions, so, we asked our colleagues to send in their questions on the COVID-19 vaccine portfolio.